<DOC>
	<DOCNO>NCT00035841</DOCNO>
	<brief_summary>The purpose study determine effectiveness TLK286 treatment metastatic breast cancer .</brief_summary>
	<brief_title>Phase 2 Study TLK286 Metastatic Breast Cancer</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Histologic diagnosis breast cancer Metastatic disease Measurable evaluable disease No prior chemotherapy regimen Age least 18 year Adequate liver kidney function Adequate bone marrow function Pregnant lactate woman Unstable medical condition Chemotherapy within 14 day TLK286 Radiation therapy within 14 day TLK286 Hormonal therapy within 14 day TLK286 Immunotherapy within 14 day TLK286 CNS metastasis unless control treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
</DOC>